Increased plasma levels of lead in patients with amyotrophic lateral sclerosis compared with control subjects as determined by flameless atomic absorption spectrophotometry.

AUTOR(ES)

Conradi, S

RESUMO

The levels of lead in plasma were determined in 16 cases of amyotrophic lateral sclerosis (ALS) and 18 control subjects, using flameless atomic absorption spectrophotometry. The mean values were 0.52+/-0.22 microgram/100ml (ALS) and 0.37+/-0.13 microgram/100ml (controls), the difference is statistically significant (5% level). The values in both groups are lower than reported earlier for normal subjects. The findings are discussed against the background of the possible pathogenetic significance of retrograde axoplasmic flow in ALS.

Documentos Relacionados

• Increased plasma lead levels in patients with amyotrophic lateral sclerosis
• Determination of urinary manganese by the direct chelation-extraction method and flameless atomic absorption spectrophotometry.
• Lead concentration in skeletal muscle in amyotrophic lateral sclerosis patients and control subjects.
• Determination of Lead in Urine by Atomic Absorption Spectrophotometry1
• Determination of Lead in Blood by Atomic Absorption Spectrophotometry1